Tavio Capital’s Teladoc Health TDOC Stock Holding History

Tavio Capital’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-160,011	Closed	-$5.3M	–	12
2017 Q3	$5.3M	Sell	160,011 -50,000	-24%	-$1.64M	2.16%	10
2017 Q2	$7.29M	Buy	+210,011	New	+$6.12M	3.63%	8

Other funds holding TDOC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Tavio Capital's TDOC Position: Q4 2017 in Review

Tavio Capital sold out of Teladoc Health (TDOC) in Q4 2017, closing a stake of 160,011 shares — an estimated $5.3M sold.

Tavio Capital first reported a position in TDOC in Q2 2017 and held it in 2 quarters. The position peaked at $7.29M in Q2 2017. 204 funds tracked by Wall St. Rank hold TDOC as of Q4 2017.

Tavio Capital reported no remaining Teladoc Health position as of Q4 2017 after selling out during the quarter.
Tavio Capital sold 160,011 Teladoc Health shares in Q4 2017, an estimated $5.3M.
Tavio Capital first reported a position in Teladoc Health in Q2 2017 and held it in 2 quarters.
Tavio Capital's Teladoc Health position peaked at $7.29M in Q2 2017.
204 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2017.

Based on Tavio Capital's 13F filing for Q4 2017, filed 12 Feb 2018.